The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction

BACKGROUND: Alterations to epithelial tight junctions can compromise the ability of the epithelium to act as a barrier between luminal contents and the underlying tissues, thereby increasing intestinal permeability, an early critical event in inflammatory bowel disease (IBD). Tofacitinib (Xeljanz),...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflamm Bowel Dis
Main Authors: Sayoc-Becerra, Anica, Krishnan, Moorthy, Fan, Shujun, Jimenez, Jossue, Hernandez, Rebecca, Gibson, Kyle, Preciado, Reyna, Butt, Grant, McCole, Declan F
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Basic Science Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012302/
https://ncbi.nlm.nih.gov/pubmed/31751457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izz266
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados